FDANonrulemakingFDA-2025-D-6131

Who commented on this docket

General Considerations for the Use of New Approach Methodologies; Draft Guidance for Industry; Availability

2 organizations filed 2 public comments on General Considerations for the Use of New Approach Methodologies; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 71d ago.

Organizations
2
Comments
2
RIN
Comment window
closed 71d ago

Abstract

Open

Commenters (2)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.